VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AlienTech who wrote (6715)	4/9/1998 11:23:00 AM
From: Herm	Read Replies (1) of 23519

There are some positive news within the VVUS earnings announcement: "VIVUS also announced today that MUSE is now approved for marketing on four continents with its recent approvals in Argentina, Brazil, South Korea and Switzerland. MUSE has been available in the US since January 1997 and in the United Kingdom since February 1998. VIVUS and its partners, Astra AB [NYSE:A - news] and Janssen Pharmaceutica, are aggressively pursuing additional international approvals with a goal of making MUSE available around the globe." More potential future business should be expected for the 2nd qtr.! "Also, during the quarter, VIVUS received Food and Drug Administration (FDA) approval of the finished packaging area contained within its new facility located in Lakewood, New Jersey. Approval of this operations area will allow the Company to transfer the final packaging of US commercial product from the current contract facilities to high speed, automated equipment in the new plant. This efficiency should result in cost savings to the Company. So, is that an FDA approval or not for the new plant? If so, they should put more emphasis on that very important event! VVUS was still limp today!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next